The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
Replimune Group Inc. announced today a key addition to its senior leadership team as it progresses its Immulytic™ oncolytic immunotherapy platform rapidly towards clinical trials.
Read the rest of entry »
Biotechnology company focused on developing next generation oncolytic immunotherapies, announced today the completion of a $55 million Series B financing.
$40 million investment to accelerate development of Immunocore’s ImmTAV® and ImmTAB® therapeutics for infectious diseases, in particular tuberculosis and HIV
The new AMSBIO CD47 protein kits are supplied as pairs of products that can be easily adapted to ELISA, AlphaLISA™ and MSD platforms to facilitate rapid and easy screening of the neutralizing compound.
A leading clinician of a top UK children’s hospital believes wireless monitoring is changing the face of healthcare.
Combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discovery to late-phase clinical development
Wickham Laboratories Ltd is pleased to announce that we will be on stand 305 at the upcoming Medtec Ireland, held on 4-5 October 2017 at the Radisson Blu Hotel in Galway, Ireland.
Construction work at the £24m Park Drive East development at Milton Park being undertaken by MEPC has reached the half way milestone
Novartis AG won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers.
Gilead Sciences is buying Kite Pharma in a deal worth $11.9 billion, securing itself access to the latter’s experimental CAR-T therapy axicabtagene ciloleucel and wider cancer pipeline.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.